9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
Atherosclerotic cardiovascular disease is a common and severe complication of diabetes. There is a large need to identify the effective and safety strategies on diabetic cardiovascular disease (DCVD). 9-PAHSA is a novel endogenous fatty acid, and has been reported to reduce blood glucose levels and...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d63894a25794b2a80922871f5ba2fea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5d63894a25794b2a80922871f5ba2fea |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5d63894a25794b2a80922871f5ba2fea2021-11-15T06:54:03Z9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice1663-981210.3389/fphar.2021.754387https://doaj.org/article/5d63894a25794b2a80922871f5ba2fea2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.754387/fullhttps://doaj.org/toc/1663-9812Atherosclerotic cardiovascular disease is a common and severe complication of diabetes. There is a large need to identify the effective and safety strategies on diabetic cardiovascular disease (DCVD). 9-PAHSA is a novel endogenous fatty acid, and has been reported to reduce blood glucose levels and attenuate inflammation. We aim to evaluate the effects of 9-PAHSA on DCVD and investigate the possible mechanisms underlying it. Firstly, serum 9-PAHSA levels in human were detected by HPLC-MS/MS analysis. Then 9-PAHSA was synthesized and purified. The synthesized 9-PAHSA was gavaged to db/db mice with 50 mg/kg for 4 weeks. The carotid arterial plaque and cardiac structure was assessed by ultrasound. Cardiac autophagy was tested by western blot analysis, electron microscope and iTRAQ. The results showed that 9-PAHSA, in patients with type 2 diabetes mellitus (T2DM), was significantly lower than that in non-diabetic subjects. Administration of 9-PAHSA for 2 weeks reduced blood glucose levels. Ultrasound observed that continue administration of 9-PAHSA for 4 weeks ameliorated carotid vascular calcification, and attenuated myocardial hypertrophy and dysfunction in db/db mice. Electron microscopy showed continue 9-PAHSA treatment significantly increased autolysosomes, while dramatically decreased greases in the myocardial cells of the db/db mice. Moreover, iTRAQ analysis exhibited that continue 9-PAHSA treatment upregulated BAG3 and HSPB8. Furthermore, western blot analysis confirmed that 9-PAHSA down-regulated Akt/mTOR and activated PI3KIII/BECN1 complex in diabetic myocardium. Thus, 9-PAHSA benefits DCVD in diabetic mice by ameliorating carotid vascular calcification, promoting autophagic flux and reducing myocardial hypertrophy.Yan-Mei WangShou-Ling MiHong JinQi-Lin GuoZhong-Yu YuJian-Tao WangXiao-Ming ZhangQian ZhangNa-Na WangYan-Yan HuangHou-Guang ZhouJing-Chun GuoFrontiers Media S.A.articlediabetic cardiovascular complicationsautophagy9-PAHSAmyocardial hypertrophyvascular calcificationTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
diabetic cardiovascular complications autophagy 9-PAHSA myocardial hypertrophy vascular calcification Therapeutics. Pharmacology RM1-950 |
spellingShingle |
diabetic cardiovascular complications autophagy 9-PAHSA myocardial hypertrophy vascular calcification Therapeutics. Pharmacology RM1-950 Yan-Mei Wang Shou-Ling Mi Hong Jin Qi-Lin Guo Zhong-Yu Yu Jian-Tao Wang Xiao-Ming Zhang Qian Zhang Na-Na Wang Yan-Yan Huang Hou-Guang Zhou Jing-Chun Guo 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice |
description |
Atherosclerotic cardiovascular disease is a common and severe complication of diabetes. There is a large need to identify the effective and safety strategies on diabetic cardiovascular disease (DCVD). 9-PAHSA is a novel endogenous fatty acid, and has been reported to reduce blood glucose levels and attenuate inflammation. We aim to evaluate the effects of 9-PAHSA on DCVD and investigate the possible mechanisms underlying it. Firstly, serum 9-PAHSA levels in human were detected by HPLC-MS/MS analysis. Then 9-PAHSA was synthesized and purified. The synthesized 9-PAHSA was gavaged to db/db mice with 50 mg/kg for 4 weeks. The carotid arterial plaque and cardiac structure was assessed by ultrasound. Cardiac autophagy was tested by western blot analysis, electron microscope and iTRAQ. The results showed that 9-PAHSA, in patients with type 2 diabetes mellitus (T2DM), was significantly lower than that in non-diabetic subjects. Administration of 9-PAHSA for 2 weeks reduced blood glucose levels. Ultrasound observed that continue administration of 9-PAHSA for 4 weeks ameliorated carotid vascular calcification, and attenuated myocardial hypertrophy and dysfunction in db/db mice. Electron microscopy showed continue 9-PAHSA treatment significantly increased autolysosomes, while dramatically decreased greases in the myocardial cells of the db/db mice. Moreover, iTRAQ analysis exhibited that continue 9-PAHSA treatment upregulated BAG3 and HSPB8. Furthermore, western blot analysis confirmed that 9-PAHSA down-regulated Akt/mTOR and activated PI3KIII/BECN1 complex in diabetic myocardium. Thus, 9-PAHSA benefits DCVD in diabetic mice by ameliorating carotid vascular calcification, promoting autophagic flux and reducing myocardial hypertrophy. |
format |
article |
author |
Yan-Mei Wang Shou-Ling Mi Hong Jin Qi-Lin Guo Zhong-Yu Yu Jian-Tao Wang Xiao-Ming Zhang Qian Zhang Na-Na Wang Yan-Yan Huang Hou-Guang Zhou Jing-Chun Guo |
author_facet |
Yan-Mei Wang Shou-Ling Mi Hong Jin Qi-Lin Guo Zhong-Yu Yu Jian-Tao Wang Xiao-Ming Zhang Qian Zhang Na-Na Wang Yan-Yan Huang Hou-Guang Zhou Jing-Chun Guo |
author_sort |
Yan-Mei Wang |
title |
9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice |
title_short |
9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice |
title_full |
9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice |
title_fullStr |
9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice |
title_full_unstemmed |
9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice |
title_sort |
9-pahsa improves cardiovascular complications by promoting autophagic flux and reducing myocardial hypertrophy in db/db mice |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/5d63894a25794b2a80922871f5ba2fea |
work_keys_str_mv |
AT yanmeiwang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT shoulingmi 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT hongjin 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT qilinguo 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT zhongyuyu 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT jiantaowang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT xiaomingzhang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT qianzhang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT nanawang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT yanyanhuang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT houguangzhou 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice AT jingchunguo 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice |
_version_ |
1718428554197204992 |